Homology Medicines Cash from Financing (TTM) Analysis

Homology Medicines Inc (DELISTED) (FIXX:DL)

0.9347 -15.76 (-94.40%) USD | NASDAQ | Mar 25, 16:00

0.92 -0.01 (-1.57%) Pre-Market: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	0.184M
September 30, 2023	0.202M
June 30, 2023	0.308M
March 31, 2023	0.306M
December 31, 2022	0.596M
September 30, 2022	0.565M
June 30, 2022	0.82M
March 31, 2022	50.57M
December 31, 2021	52.17M
September 30, 2021	104.16M
June 30, 2021	104.19M
March 31, 2021	54.69M
December 31, 2020	53.09M

Date	Value
September 30, 2020	23.67M
June 30, 2020	23.88M
March 31, 2020	158.34M
December 31, 2019	158.21M
September 30, 2019	135.68M
June 30, 2019	135.09M
March 31, 2019	152.28M
December 31, 2018	150.99M
September 30, 2018	162.62M
June 30, 2018	245.68M
March 31, 2018	93.79M
December 31, 2017	115.23M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.184M

Minimum

Dec 2023

158.34M

Maximum

Mar 2020

55.62M

Average

50.57M

Median

Mar 2022

Cash from Financing (TTM) Benchmarks